Results 161 to 170 of about 7,460 (217)

Reactive oxygen species: Orchestrating the delicate dance of platelet life and death. [PDF]

Redox Biol
Liao R, Wang L, Zeng J, Tang X, Huang M, Kantawong F, Huang Q, Mei Q, Huang F, Yang Y, Liao B, Wu A, Wu J.   +12 more
europepmc   +1 more source

Phillyrin alleviates Kawasaki disease-induced lung inflammation by inhibiting platelet production through the NLRP3/IL-1β/NF-E2 signaling pathway. [PDF]

Chin Med
Mai DH, Huang X, Liang M, Yu X, Hao W, Yang LW, Feng JR, Ling XL, Wang K, Zhu L, Chen Y.   +10 more
europepmc   +1 more source

Genetic variability in thrombopoietin receptor and GATA1 influences response to eltrombopag in dengue-induced thrombocytopenia. [PDF]

Sci Rep
Sayem M, Rimon RA, Alam S, Saba AA, Sanyal M, Sayem M, Tabassum CT, Amin MR, Chakraborty S, Kabir A, Nabi AHMN.   +10 more
europepmc   +1 more source

Normal and malignant hematopoiesis [PDF]

, 2017
Fey, MF
core  

Versatility of megakaryocytes in homeostasis and disease. [PDF]

Blood Sci
Wang D, Xie J, Zhao M.
europepmc   +1 more source

Dose-dependent effects of eltrombopag iron chelation on platelet formation. [PDF]

Blood Vessel Thromb Hemost
Bassi E, Abbonante V, Aguilar A, Raslova H, Bussel JB, Di Buduo CA, Malara A, Balduini A.   +7 more
europepmc   +1 more source

The Mechanisms behind Thrombocytopenia in Patients with Portal Hypertension and Chronic Liver Disease. [PDF]

J Clin Transl Hepatol
Fernández-Garibay VM, Ramírez-Mejia MM, Ponciano-Rodriguez G, Wang R, Qi X, Méndez-Sánchez N.   +5 more
europepmc   +1 more source

Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial. [PDF]

Blood Adv
Lachey J, Rovaldi C, Bobba S, Tur J, Natarajan H, Snyder B, Seehra J.   +6 more
europepmc   +1 more source

Acquired platelet disorders. [PDF]

Front Med (Lausanne)
Altahan RM.
europepmc   +1 more source